Shakti Ketan Prusty

Modeling of chitosan modified PLGA atorvastatin-curcumin conjugate (AT-CU) nanoparticles, overcoming the barriers associated with PLGA: An approach for better management of atherosclerosis

Rasmita Dash, Madhulika Yadav, Jyotirmaya Biswal et al. · International Journal of Pharmaceutics · 2023 · 29 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutical Biotechnology +14

A recent update on drugs and alternative approaches for parkinsonism

Sneha Kispotta, Debajyoti Das, Shakti Ketan Prusty · Neuropeptides · 2024 · 20 citations

Medicine, Neurology, Pharmacotherapy +14

Captopril is more effective than Perindopril against aluminium chloride induced amyloidogenesis and AD like pathology

Debashish Mohapatra, Srikanta Kanungo, Sweta Priyadarshini Pradhan et al. · Heliyon · 2022 · 19 citations · Full text

Medicine, Neuroscience, Pharmacology +13

Novel atorvastatin-curcumin conjugate nanogel, a selective COX2 inhibitor with enhanced biopharmaceutical profile: Design, synthesis, in silico, in vitro, and in vivo investigation

Rasmita Dash, Jyotirmaya Biswal, Madhulika Yadav et al. · Journal of Drug Delivery Science and Technology · 2023 · 17 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Conjugation to Ascorbic Acid Enhances Brain Availability of Losartan Carboxylic Acid and Protects Against Parkinsonism in Rats

Bharat Bhusan Subudhi, Pratap Kumar Sahu, Vijay Kumar Singh et al. · The AAPS Journal · 2018 · 15 citations

Life Sciences, Neuroscience, Pharmacology +16